Equitable HPV vaccination for all

Designing around lives: A decentralised, people-centred oncology care architecture from India

Subcutaneous tarlatamab shows encouraging efficacy in previously treated extensive-stage SCLC

Pembrolizumab plus chemotherapy shows pathological responses in resectable pleural mesothelioma

TELENEC reduces referral delays for childhood cancer care in Paraguay

Adjuvant osimertinib delivers sustained long term survival benefit in EGFR mutated NSCLC

Cemiplimab shows strong survival benefit in KRAS G12C positive advanced NSCLC

Challenges in doing clinical research in the LATAM region

Amivantamab plus chemotherapy extends overall survival in EGFR exon 20 insertion NSCLC

Biomarker guided PARP inhibitor maintenance improves outcomes in ovarian cancer meta analysis of phase 3 trials

Immune checkpoint inhibitors show setting specific benefit in ovarian cancer meta analysis of 17 randomised trials

Prolgolimab plus chemotherapy improves long term survival in advanced nonsquamous NSCLC